4//SEC Filing
MAHONEY DAVID L 4
Accession 0000950170-25-075470
CIK 0001088856other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:13 PM ET
Size
13.2 KB
Accession
0000950170-25-075470
Insider Transaction Report
Form 4
MAHONEY DAVID L
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-16$6.55/sh+30,000$196,500→ 30,000 total - Tax Payment
Common Stock
2025-05-16$74.21/sh−2,648$196,508→ 27,352 total - Exercise/Conversion
Stock option (right to buy)
2025-05-16−30,000→ 0 totalExercise: $6.55Exp: 2025-06-18→ Common Stock (30,000 underlying) - Sale
Common Stock
2025-05-16$74.17/sh−23,829$1,767,452→ 3,523 total - Sale
Common Stock
2025-05-16$74.65/sh−3,523$263,001→ 0 total
Holdings
- 46,147(indirect: By Foundation)
Common Stock
- 1,212,614(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price liability arising from a net (cashless) exercise of stock options that occurred on May 16, 2025. The options subject to the net exercise were to expire on June 18, 2025.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.54 to $74.525 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.54 to $74.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001224091
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:13 PM ET
- Size
- 13.2 KB